Trial Profile
Exploratory study investigating ocular blood flow in colorectal cancer patients before and after treatment with anti-angiogenic therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Sep 2022
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 21 Sep 2022 Status changed from recruiting to completed.
- 09 Jul 2014 New trial record